These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 17138499

  • 1. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M, Kravzov-Jinich J, Guadarrama-Atrizco MD, Rubio-Poo C, Wertheimer AI.
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive persistence and drug class.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB.
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [Abstract] [Full Text] [Related]

  • 4. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B, Angman A, Hjemdahl P.
    Lakartidningen; 2002 Jun; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract] [Full Text] [Related]

  • 5. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy.
    Maio V, Gagne JJ.
    J Clin Pharm Ther; 2010 Feb; 35(1):55-61. PubMed ID: 20175812
    [Abstract] [Full Text] [Related]

  • 6. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE, Mohiuddin SM, Lucas BD, Stading JA, Stoysich AM, Ryschon K.
    Clin Ther; 1994 Feb; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [Abstract] [Full Text] [Related]

  • 7. Impact of restrictive prescription plans on heart failure medication use.
    Thanassoulis G, Karp I, Humphries K, Tu JV, Eisenberg MJ, Pilote L.
    Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
    [Abstract] [Full Text] [Related]

  • 8. Reducing costs and improving hypertension management.
    Stankus V, Hemmelgarn B, Campbell NR, Chen G, McAlister FA, Tsuyuki RT.
    Can J Clin Pharmacol; 2009 Sep; 16(1):e151-5. PubMed ID: 19193969
    [Abstract] [Full Text] [Related]

  • 9. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA, Sequeira RP.
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [Abstract] [Full Text] [Related]

  • 10. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M, Sulem P, Chastan E, Niezborala M, Briant D, Jansou P, Sanguignol F, Montastruc JL.
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO, Okubadejo NU.
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract] [Full Text] [Related]

  • 12. [Use of antihypertensive drugs in Spain, 1985-1995].
    Prieto M, de Abajo FJ, Montero D, Martín-Serrano G, Madurga M, Palop R.
    Med Clin (Barc); 1998 Feb 28; 110(7):247-53. PubMed ID: 9562948
    [Abstract] [Full Text] [Related]

  • 13. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
    Xie F, Petitti DB, Chen W.
    Am J Hypertens; 2005 Apr 28; 18(4 Pt 1):464-9. PubMed ID: 15831354
    [Abstract] [Full Text] [Related]

  • 14. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y, Sasamura H, Ikeda S, Ikegami N, Saruta T.
    Hypertens Res; 2006 May 28; 29(5):333-8. PubMed ID: 16832153
    [Abstract] [Full Text] [Related]

  • 15. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD, Dufresne L, LeBlanc D.
    Can Fam Physician; 1998 Feb 28; 44():294-8, 301-2. PubMed ID: 9512833
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002.
    Lopez J, Meier J, Cunningham F, Siegel D.
    Am J Hypertens; 2004 Dec 28; 17(12 Pt 1):1095-9. PubMed ID: 15607614
    [Abstract] [Full Text] [Related]

  • 17. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K.
    Tidsskr Nor Laegeforen; 2001 Feb 28; 121(6):701-5. PubMed ID: 11293353
    [Abstract] [Full Text] [Related]

  • 18. [Utilization of cardiovascular drugs in Denmark from 1978 to 1990].
    Johansen UE, Nielsen PE.
    Ugeskr Laeger; 1992 Aug 03; 154(32):2205-8. PubMed ID: 1509607
    [Abstract] [Full Text] [Related]

  • 19. Advertising of antihypertensive medicines and prescription sales in Australia.
    Vitry A, Lai YH.
    Intern Med J; 2009 Nov 03; 39(11):728-32. PubMed ID: 19226422
    [Abstract] [Full Text] [Related]

  • 20. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A, Tomić Z, Milijasević B, Ban M, Horvat O, Vukmirović S, Sabo A.
    Vojnosanit Pregl; 2016 Jun 03; 73(6):531-7. PubMed ID: 27498444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.